Assessment of the healing rate of erosive or ulcerative esophagitis after two and four weeks of treatment with S-tenatoprazole-Na (STU-Na) 15 Mg, 30 Mg, 60 Mg, 90 Mg and esomeprazole 40 Mg. A multicenter, randomized, double-blind, parallel group study

Trial Profile

Assessment of the healing rate of erosive or ulcerative esophagitis after two and four weeks of treatment with S-tenatoprazole-Na (STU-Na) 15 Mg, 30 Mg, 60 Mg, 90 Mg and esomeprazole 40 Mg. A multicenter, randomized, double-blind, parallel group study

Suspended
Phase of Trial: Phase II

Latest Information Update: 27 Nov 2006

At a glance

  • Drugs Esomeprazole; Tenatoprazole
  • Indications Erosive oesophagitis; Heartburn; Oesophagitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top